How effective is Atrovent for Chronic Obstructive Pulmonary Disease? (a real world drug study)
Summary:
Overall ratings: 3.1/5 Long term ratings: 3.1/5
This is a phase IV clinical study of how effective Atrovent (ipratropium bromide) is for Chronic obstructive pulmonary disease and for what kind of people. The study is created by eHealthMe from 28 Atrovent users and is updated continuously.
What is Atrovent?
Atrovent has active ingredients of ipratropium bromide. It is often used in chronic obstructive pulmonary disease. eHealthMe is studying from 33,210 Atrovent users. Check the latest studies of Atrovent.
What is Chronic obstructive pulmonary disease?
Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe) is found to be associated with 1,803 drugs and 2,209 conditions by eHealthMe. Check the latest studies of Chronic obstructive pulmonary disease.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
28 people are studied for taking Atrovent in Chronic obstructive pulmonary disease
Overall effectiveness (number of people):
Long term (1+ years) effectiveness (number of people):
Atrovent effectiveness for Chronic obstructive pulmonary disease (number of people):
Overall:
- not at all: 1
- somewhat: 4
- moderate: 15
- high: 7
- very high: 1
Long Term:
- not at all: 0
- somewhat: 3
- moderate: 8
- high: 3
- very high: 1
Gender of people who take Atrovent for Chronic obstructive pulmonary disease *:
- female: 60.71 %
- male: 39.29 %
Age of people who take Atrovent for Chronic obstructive pulmonary disease *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 3.5700000000000003 %
- 50-59: 14.29 %
- 60+: 82.14 %
Who find Atrovent more effective for Chronic Obstructive Pulmonary Disease?
Gender of people who take Atrovent for Chronic obstructive pulmonary disease *:
- female: 62.5 %
- male: 37.5 %
Age of people who take Atrovent for Chronic obstructive pulmonary disease *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 12.5 %
- 50-59: 12.5 %
- 60+: 75.0 %
* Approximation only. Some reports may have incomplete information.
Do you take Atrovent?
- You can start a phase IV clinical trial to monitor Atrovent safety and effectiveness.How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related studies
Alternative drugs to, pros and cons of:
- Atrovent (33,210 reports)
Treatments, associated drugs and conditions:
- Chronic obstructive pulmonary disease (198,253 reports)
How the study uses the data?
The study is based on ipratropium bromide (the active ingredients of Atrovent) and Atrovent (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study neither.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Ticagrelor cause High Blood Pressure? - 2 seconds ago
- Hydrocortisone and Emotional Distress for Men aged 60+ - 4 seconds ago
- Drug interactions of Vesicare and Xeljanz - 18 seconds ago
- Drug interactions of Creatine and Ademetionine - 22 seconds ago
- Sertraline and Swelling Of Fingers for Men aged 60+ - 22 seconds ago
- Sertraline and Toe Swelling for Men aged 60+ - 22 seconds ago
- Sertraline and Swelling Of A Joint for Men aged 60+ - 23 seconds ago
- Sertraline and Knee Swelling for Men aged 60+ - 23 seconds ago
- Sertraline and Hip Swelling for Men aged 60+ - 23 seconds ago
- Sertraline and Finger Swelling for Men aged 60+ - 24 seconds ago